SMAD2 and breast cancer: Given that canonical and non-canonical TGFβ pathways affect chromatin accessibility [59] and that CDK4/6 inhibition induces chromatin remodelling by enhancer activation in breast cancer [52], SMAD2 splice variants and corresponding phospho-isoforms are critical modulators of gene transcription in NSCLC.